nedaplatin has been researched along with ifosfamide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, Y; Hirabayashi, K; Nakanishi, Y; Nakazuma, Y; Ohta, M; Okada, E; Sezaki, H | 1 |
| Hirabayashi, K; Okada, E | 1 |
| Akima, S; Horiuchi, K; Tsuboi, N; Yoshida, K | 1 |
| Hatae, M; Hirabayashi, K; Kanazawa, K; Noda, K; Ozaki, M; Terashima, Y; Yakushiji, M | 1 |
| Akasaka, Y; Igarashi, H; Kondou, N; Kuroda, A; Madarame, J; Nakata, J; Ohishi, Y; Tomita, M; Yanada, S | 1 |
| Demura, T; Harabayashi, T; Ishikawa, R; Koyanagi, T; Mitsuhashi, K; Murakumo, M; Seki, H; Shinohara, N; Suzuki, S; Toyota, H | 1 |
| Achiwa, H; Bessho, Y; Hattori, N; Kato, D; Maeda, H; Niimi, T; Oguri, T; Sato, S; Shimizu, S; Ueda, R | 1 |
| Demura, T; Harabayashi, T; Matsuyama, H; Mitsuhashi, K; Murakumo, M; Nagamori, S; Nagao, K; Naito, K; Nonomura, K; Seki, H; Shinohara, N; Suzuki, S | 1 |
| Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T | 1 |
| Fukumori, T; Harada, A; Hayashi, H; Izaki, H; Kanayama, HO; Kishimoto, T; Nishitani, MA; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
| Inoue, H; Miki, T; Mizutani, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A | 1 |
| Fukuta, F; Kitamura, H; Kunishima, Y; Masumori, N; Mutoh, M; Shigyo, M; Taguchi, K; Takahashi, A; Tanaka, T; Tsukamoto, T; Yanase, M | 1 |
| Hasegawa, K; Kato, R; Kawamura, K; Kobayashi, Y; Okamoto, H; Sekiya, T; Udagawa, Y | 1 |
| Arai, Y; Ishidoya, S; Ito, A; Kaiho, Y; Mitsuzuka, K; Miyazato, M; Nakagawa, H; Namiki, S; Ohara, S; Saito, H; Yamada, S; Yamashita, S | 1 |
| Kamata, S; Yoshinaga, A | 1 |
| Fujihara, A; Hongo, F; Kamoi, K; Miki, T; Nakamura, T; Nakanishi, H; Naya, Y; Oishi, M; Okihara, K; Ueda, T | 1 |
| Fujisawa, M; Miyake, H; Nishikawa, M | 1 |
| Fujii, N; Inoue, R; Kobayashi, K; Matsumoto, H; Matsuyama, H; Nagao, K; Shimizu, K; Yamamoto, Y | 1 |
| Haraga, J; Ida, N; Kiyotoki, T; Kusumoto, T; Masuyama, H; Nakamura, K; Nishida, T; Omichi, C; Saijo, M | 1 |
| Hosomi, T; Makino, Y; Otsuka, H; Shibasaki, N; Shichiri, Y; Uketa, S | 1 |
5 trial(s) available for nedaplatin and ifosfamide
| Article | Year |
|---|---|
Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intramuscular; Melanoma, Experimental; Mice; Mice, Inbred Strains; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Organoplatinum Compounds; Peplomycin; Prognosis; Skin Neoplasms; Uterine Cervical Neoplasms | 1993 |
[Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Nausea; Organoplatinum Compounds; Pilot Projects; Uterine Cervical Neoplasms; Vomiting | 1997 |
Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Treatment Outcome; Urologic Neoplasms | 2006 |
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2007 |
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2011 |
15 other study(ies) available for nedaplatin and ifosfamide
| Article | Year |
|---|---|
[Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Peplomycin; Prognosis; Uterine Cervical Neoplasms | 1992 |
[Evaluation of the chemotherapy of a transplantable bladder tumour strain (NM-B-1) by two anti-cancer drugs in combination with a pressor agent in nude mice].
Topics: Angiotensin II; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Therapy, Combination; Humans; Ifosfamide; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Urinary Bladder Neoplasms | 1995 |
[High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
[Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Survival Rate; Thrombocytopenia; Urologic Neoplasms | 2004 |
[A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Organoplatinum Compounds; Thymus Neoplasms; Tomography, X-Ray Computed | 2005 |
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retroperitoneal Neoplasms | 2006 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Thymidine Phosphorylase; Uterine Cervical Neoplasms | 2012 |
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Recurrence; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2013 |
[Long survival in a patient with advanced ureteral carcinoma treated with TIN regimen (paclitaxel, ifosfamide, nedaplatin) and radiotherapy : a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Humans; Ifosfamide; Male; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Ureteral Neoplasms | 2014 |
Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2015 |
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Camptothecin; Cisplatin; Etoposide; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retreatment; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2016 |
Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Paclitaxel; Prognosis; Retrospective Studies; Treatment Outcome; Urethral Neoplasms | 2016 |
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Sarcopenia; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
[Advanced Bladder Cancer with Multiple Pulmonary Metastases Treated with Paclitaxel/Ifosfamide/Nedaplatin Therapy : Two Case Reports].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Paclitaxel; Urinary Bladder Neoplasms | 2023 |